A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils

Lorena Saelices, Binh A. Nguyen, Kevin Chung, Yifei Wang, Alfredo Ortega, Ji H. Lee, Teresa Coelho, Johan Bijzet, Merrill Benson, David S. Eisenberg

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The tetrameric protein transthyretin is a transporter of retinol and thyroxine in blood, cerebrospinal fluid, and the eye, and is secreted by the liver, choroid plexus, and retinal epithelium, respectively. Systemic amyloid deposition of aggregated transthyretin causes hereditary and sporadic amyloidoses. A common treatment of patients with hereditary transthyretin amyloidosis is liver transplantation. However, this procedure, which replaces the patient’s variant transthyretin with the WT protein, can fail to stop subsequent cardiac deposition, ultimately requiring heart transplantation. We recently showed that preformed amyloid fibrils present in the heart at the time of surgery can template or seed further amyloid aggregation of native transthyretin. Here we assess possible interventions to halt this seeding, using biochemical and EM assays. We found that chemical or mutational stabilization of the transthyretin tetramer does not hinder amyloid seeding. In contrast, binding of the peptide inhibitor TabFH2 to ex vivo fibrils efficiently inhibits amyloid seeding by impeding self-association of the amyloid-driving strands F and H in a tissue-independent manner. Our findings point to inhibition of amyloid seeding by peptide inhibitors as a potential therapeutic approach.

Original languageEnglish (US)
Pages (from-to)6130-6141
Number of pages12
JournalJournal of Biological Chemistry
Volume294
Issue number15
DOIs
StatePublished - Jan 1 2019

Fingerprint

Prealbumin
Amyloid
Hormones
Peptides
Familial Amyloidosis
Liver
Cerebrospinal fluid
Choroid Plexus
Heart Transplantation
Vitamin A
Thyroxine
Liver Transplantation
Surgery
Cerebrospinal Fluid
Seed
Assays
Seeds
Proteins
Blood
Agglomeration

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Saelices, L., Nguyen, B. A., Chung, K., Wang, Y., Ortega, A., Lee, J. H., ... Eisenberg, D. S. (2019). A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils. Journal of Biological Chemistry, 294(15), 6130-6141. https://doi.org/10.1074/jbc.RA118.005257

A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils. / Saelices, Lorena; Nguyen, Binh A.; Chung, Kevin; Wang, Yifei; Ortega, Alfredo; Lee, Ji H.; Coelho, Teresa; Bijzet, Johan; Benson, Merrill; Eisenberg, David S.

In: Journal of Biological Chemistry, Vol. 294, No. 15, 01.01.2019, p. 6130-6141.

Research output: Contribution to journalArticle

Saelices, L, Nguyen, BA, Chung, K, Wang, Y, Ortega, A, Lee, JH, Coelho, T, Bijzet, J, Benson, M & Eisenberg, DS 2019, 'A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils', Journal of Biological Chemistry, vol. 294, no. 15, pp. 6130-6141. https://doi.org/10.1074/jbc.RA118.005257
Saelices, Lorena ; Nguyen, Binh A. ; Chung, Kevin ; Wang, Yifei ; Ortega, Alfredo ; Lee, Ji H. ; Coelho, Teresa ; Bijzet, Johan ; Benson, Merrill ; Eisenberg, David S. / A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils. In: Journal of Biological Chemistry. 2019 ; Vol. 294, No. 15. pp. 6130-6141.
@article{f4e27a7ef9ba4066bf48baab3e36d25f,
title = "A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils",
abstract = "The tetrameric protein transthyretin is a transporter of retinol and thyroxine in blood, cerebrospinal fluid, and the eye, and is secreted by the liver, choroid plexus, and retinal epithelium, respectively. Systemic amyloid deposition of aggregated transthyretin causes hereditary and sporadic amyloidoses. A common treatment of patients with hereditary transthyretin amyloidosis is liver transplantation. However, this procedure, which replaces the patient’s variant transthyretin with the WT protein, can fail to stop subsequent cardiac deposition, ultimately requiring heart transplantation. We recently showed that preformed amyloid fibrils present in the heart at the time of surgery can template or seed further amyloid aggregation of native transthyretin. Here we assess possible interventions to halt this seeding, using biochemical and EM assays. We found that chemical or mutational stabilization of the transthyretin tetramer does not hinder amyloid seeding. In contrast, binding of the peptide inhibitor TabFH2 to ex vivo fibrils efficiently inhibits amyloid seeding by impeding self-association of the amyloid-driving strands F and H in a tissue-independent manner. Our findings point to inhibition of amyloid seeding by peptide inhibitors as a potential therapeutic approach.",
author = "Lorena Saelices and Nguyen, {Binh A.} and Kevin Chung and Yifei Wang and Alfredo Ortega and Lee, {Ji H.} and Teresa Coelho and Johan Bijzet and Merrill Benson and Eisenberg, {David S.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1074/jbc.RA118.005257",
language = "English (US)",
volume = "294",
pages = "6130--6141",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "15",

}

TY - JOUR

T1 - A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils

AU - Saelices, Lorena

AU - Nguyen, Binh A.

AU - Chung, Kevin

AU - Wang, Yifei

AU - Ortega, Alfredo

AU - Lee, Ji H.

AU - Coelho, Teresa

AU - Bijzet, Johan

AU - Benson, Merrill

AU - Eisenberg, David S.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The tetrameric protein transthyretin is a transporter of retinol and thyroxine in blood, cerebrospinal fluid, and the eye, and is secreted by the liver, choroid plexus, and retinal epithelium, respectively. Systemic amyloid deposition of aggregated transthyretin causes hereditary and sporadic amyloidoses. A common treatment of patients with hereditary transthyretin amyloidosis is liver transplantation. However, this procedure, which replaces the patient’s variant transthyretin with the WT protein, can fail to stop subsequent cardiac deposition, ultimately requiring heart transplantation. We recently showed that preformed amyloid fibrils present in the heart at the time of surgery can template or seed further amyloid aggregation of native transthyretin. Here we assess possible interventions to halt this seeding, using biochemical and EM assays. We found that chemical or mutational stabilization of the transthyretin tetramer does not hinder amyloid seeding. In contrast, binding of the peptide inhibitor TabFH2 to ex vivo fibrils efficiently inhibits amyloid seeding by impeding self-association of the amyloid-driving strands F and H in a tissue-independent manner. Our findings point to inhibition of amyloid seeding by peptide inhibitors as a potential therapeutic approach.

AB - The tetrameric protein transthyretin is a transporter of retinol and thyroxine in blood, cerebrospinal fluid, and the eye, and is secreted by the liver, choroid plexus, and retinal epithelium, respectively. Systemic amyloid deposition of aggregated transthyretin causes hereditary and sporadic amyloidoses. A common treatment of patients with hereditary transthyretin amyloidosis is liver transplantation. However, this procedure, which replaces the patient’s variant transthyretin with the WT protein, can fail to stop subsequent cardiac deposition, ultimately requiring heart transplantation. We recently showed that preformed amyloid fibrils present in the heart at the time of surgery can template or seed further amyloid aggregation of native transthyretin. Here we assess possible interventions to halt this seeding, using biochemical and EM assays. We found that chemical or mutational stabilization of the transthyretin tetramer does not hinder amyloid seeding. In contrast, binding of the peptide inhibitor TabFH2 to ex vivo fibrils efficiently inhibits amyloid seeding by impeding self-association of the amyloid-driving strands F and H in a tissue-independent manner. Our findings point to inhibition of amyloid seeding by peptide inhibitors as a potential therapeutic approach.

UR - http://www.scopus.com/inward/record.url?scp=85064350539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064350539&partnerID=8YFLogxK

U2 - 10.1074/jbc.RA118.005257

DO - 10.1074/jbc.RA118.005257

M3 - Article

C2 - 30733338

AN - SCOPUS:85064350539

VL - 294

SP - 6130

EP - 6141

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 15

ER -